0001225208-19-004340.txt : 20190304 0001225208-19-004340.hdr.sgml : 20190304 20190304162941 ACCESSION NUMBER: 0001225208-19-004340 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190301 FILED AS OF DATE: 20190304 DATE AS OF CHANGE: 20190304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ballinger Kevin J. CENTRAL INDEX KEY: 0001566080 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 19654151 MAIL ADDRESS: STREET 1: C/O BOSTON SCIENTIFIC CORPORATION STREET 2: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 4 1 doc4.xml X0306 4 2019-03-01 0000885725 BOSTON SCIENTIFIC CORP BSX 0001566080 Ballinger Kevin J. 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 1 EVP & Pres, Interven Cardio Common Stock 2019-03-01 4 S 0 20900.0000 40.7441 D 77572.0000 D Common Stock 2019-03-03 4 M 0 3302.0000 0.0000 A 80874.0000 D Common Stock 2019-03-03 4 F 0 1506.0000 40.7500 D 79368.0000 D Deferred Stock Units 2019-03-03 4 M 0 3302.0000 0.0000 D 2022-03-03 Common Stock 3302.0000 9909.0000 D This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $40.74 to $40.76, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on March 3, 2018, the first anniversary of the date of grant. /s/ Scott G. Hodgdon, Attorney-in-Fact 2019-03-04